251 related articles for article (PubMed ID: 22486269)
41. Human CCR4+ CCR6+ Th17 cells suppress autologous CD8+ T cell responses.
Zhao F; Hoechst B; Gamrekelashvili J; Ormandy LA; Voigtländer T; Wedemeyer H; Ylaya K; Wang XW; Hewitt SM; Manns MP; Korangy F; Greten TF
J Immunol; 2012 Jun; 188(12):6055-62. PubMed ID: 22615204
[TBL] [Abstract][Full Text] [Related]
42. Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients.
Veny M; Esteller M; Ricart E; Piqué JM; Panés J; Salas A
Aliment Pharmacol Ther; 2010 Mar; 31(5):561-72. PubMed ID: 19958311
[TBL] [Abstract][Full Text] [Related]
43. Cytokine flexibility of early and differentiated memory T helper cells in juvenile idiopathic arthritis.
Chiesa S; Prigione I; Morandi F; Buoncompagni A; Picco P; Bocca P; Martini A; Pistoia V; Gattorno M
J Rheumatol; 2004 Oct; 31(10):2048-54. PubMed ID: 15468374
[TBL] [Abstract][Full Text] [Related]
44. Unlike αβ T cells, γδ T cells, LTi cells and NKT cells do not require IRF4 for the production of IL-17A and IL-22.
Raifer H; Mahiny AJ; Bollig N; Petermann F; Hellhund A; Kellner K; Guralnik A; Reinhard K; Bothur E; Huber M; Bauer S; Löhning M; Kiss EA; Ganal SC; Diefenbach A; Korn T; Lohoff M
Eur J Immunol; 2012 Dec; 42(12):3189-201. PubMed ID: 22961652
[TBL] [Abstract][Full Text] [Related]
45. A sharp decrease of Th17, CXCR3+-Th17, and Th17.1 in peripheral blood is associated with an early anti-IL-17-mediated clinical remission in psoriasis.
Tsiogkas SG; Mavropoulos A; Dardiotis E; Zafiriou E; Bogdanos DP
Clin Exp Immunol; 2022 Oct; 210(1):79-89. PubMed ID: 35925616
[TBL] [Abstract][Full Text] [Related]
46. Increased IL-17-producing CD4(+) T cells in patients with esophageal cancer.
Chen D; Hu Q; Mao C; Jiao Z; Wang S; Yu L; Xu Y; Dai D; Yin L; Xu H
Cell Immunol; 2012; 272(2):166-74. PubMed ID: 22082565
[TBL] [Abstract][Full Text] [Related]
47. Intranasal immunization promotes th17 immune responses.
Zygmunt BM; Rharbaoui F; Groebe L; Guzman CA
J Immunol; 2009 Dec; 183(11):6933-8. PubMed ID: 19890060
[TBL] [Abstract][Full Text] [Related]
48. Activation of peripheral Th17 lymphocytes in patients with asthma.
Wong CK; Lun SW; Ko FW; Wong PT; Hu SQ; Chan IH; Hui DS; Lam CW
Immunol Invest; 2009; 38(7):652-64. PubMed ID: 19811428
[TBL] [Abstract][Full Text] [Related]
49. Nickel-responding T cells are CD4+ CLA+ CD45RO+ and express chemokine receptors CXCR3, CCR4 and CCR10.
Moed H; Boorsma DM; Stoof TJ; von Blomberg BM; Bruynzeel DP; Scheper RJ; Gibbs S; Rustemeyer T
Br J Dermatol; 2004 Jul; 151(1):32-41. PubMed ID: 15270870
[TBL] [Abstract][Full Text] [Related]
50. Ex vivo IL-1 receptor type I expression in human CD4+ T cells identifies an early intermediate in the differentiation of Th17 from FOXP3+ naive regulatory T cells.
Raffin C; Raimbaud I; Valmori D; Ayyoub M
J Immunol; 2011 Nov; 187(10):5196-202. PubMed ID: 21998454
[TBL] [Abstract][Full Text] [Related]
51. Increased serum interleukin-17 and peripheral Th17 cells in children with acute Henoch-Schönlein purpura.
Jen HY; Chuang YH; Lin SC; Chiang BL; Yang YH
Pediatr Allergy Immunol; 2011 Dec; 22(8):862-8. PubMed ID: 21929599
[TBL] [Abstract][Full Text] [Related]
52. Urinary T cells in active lupus nephritis show an effector memory phenotype.
Dolff S; Abdulahad WH; van Dijk MC; Limburg PC; Kallenberg CG; Bijl M
Ann Rheum Dis; 2010 Nov; 69(11):2034-41. PubMed ID: 20472588
[TBL] [Abstract][Full Text] [Related]
53. Evidence for a pathogenic role of extrafollicular, IL-10-producing CCR6
Facciotti F; Larghi P; Bosotti R; Vasco C; Gagliani N; Cordiglieri C; Mazzara S; Ranzani V; Rottoli E; Curti S; Penatti A; Karnani B; Kobayashi Y; Crosti M; Bombaci M; van Hamburg JP; Rossetti G; Gualtierotti R; Gerosa M; Gatti S; Torretta S; Pignataro L; Tas SW; Abrignani S; Pagani M; Grassi F; Meroni PL; Flavell RA; Geginat J
Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7305-7316. PubMed ID: 32184325
[TBL] [Abstract][Full Text] [Related]
54. Tobacco smoke is related to Th17 generation with clinical implications for psoriasis patients.
Torii K; Saito C; Furuhashi T; Nishioka A; Shintani Y; Kawashima K; Kato H; Morita A
Exp Dermatol; 2011 Apr; 20(4):371-3. PubMed ID: 21355889
[TBL] [Abstract][Full Text] [Related]
55. Human Memory Th17 Cell Populations Change Into Anti-inflammatory Cells With Regulatory Capacity Upon Exposure to Active Vitamin D.
Dankers W; Davelaar N; van Hamburg JP; van de Peppel J; Colin EM; Lubberts E
Front Immunol; 2019; 10():1504. PubMed ID: 31379807
[TBL] [Abstract][Full Text] [Related]
56. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis.
Shen H; Goodall JC; Hill Gaston JS
Arthritis Rheum; 2009 Jun; 60(6):1647-56. PubMed ID: 19479869
[TBL] [Abstract][Full Text] [Related]
57. Statins inhibit chemotactic interaction between CCL20 and CCR6 in vitro: possible relevance to psoriasis treatment.
Kim TG; Byamba D; Wu WH; Lee MG
Exp Dermatol; 2011 Oct; 20(10):855-7. PubMed ID: 21824198
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of IL-17 Producing Memory Regulatory and Effector T Cells Expressing CD26 Molecule in Patients with Psoriasis.
Esmaeili B; Mansouri P; Meysamie A; Izad M
Iran J Allergy Asthma Immunol; 2018 Oct; 17(5):453-463. PubMed ID: 30518187
[TBL] [Abstract][Full Text] [Related]
59. Recruitment of CCR6-expressing Th17 cells by CCL20 secreted from plasmin-stimulated macrophages.
Li Q; Laumonnier Y; Syrovets T; Simmet T
Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):593-600. PubMed ID: 23681234
[TBL] [Abstract][Full Text] [Related]
60. Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response.
Quaglino P; Bergallo M; Ponti R; Barberio E; Cicchelli S; Buffa E; Comessatti A; Costa C; Terlizzi ME; Astegiano S; Novelli M; Cavallo R; Bernengo MG
Dermatology; 2011; 223(1):57-67. PubMed ID: 21865674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
